Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60

By Falsey A.R.   Walsh E.E.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1214-1218

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the Western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection

By Piedra P.A.   Glezen W.P.   Kasel J.A.   Welliver R.C.   Jewel A.M.   Rayford Y.   Hogerman D.A.   Hildreth S.W.   Paradiso P.R.  

Vaccine, Vol. 13, Iss. 12, 1995-08 ,pp. : 1095-1101

Elsevier

Access to resources Recommend Favorite

The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B

By Power U.F.   Plotnicky H.   Blaecke A.   Nguyen T.N.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 168-176

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women

By Munoz F.M.   Piedra P.A.   Glezen W.P.  

Vaccine, Vol. 21, Iss. 24, 2003-07 ,pp. : 3465-3467

Elsevier

Access to resources Recommend Favorite

Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate

By Goetsch L.   Plotnicky-Gilquin H.   Champion T.   Beck A.   Corvaa N.   Stahl S.   Bonnefoy J.-Y.   Nguyen T.N.   Power U.F.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2735-2742

Elsevier

Access to resources Recommend Favorite